Liver transplantation (LT) is the optimal therapeutic option for patients with liver cirrhosis and
hepatocellular carcinoma (HCC). Due to universal donor shortage, only the patients with …

Liver transplantation is the most successful treatment for limited-stage HCC. The waiting
time for liver transplantation (LT) can be a critical factor affecting the oncological prognosis …

Background: Liver transplantation offers the best chance of cure for most patients with non-
metastatic hepatocellular carcinoma (HCC). Although not all patients with HCC are eligible …

Abstract In the United States, 80%-90% of primary hepatic tumors are hepatocellular
carcinomas and 10%-15% are cholangiocarcinomas (CCA), both with high mortality rate …

Background Owing to remarkable improvements of surgical techniques and associated
specialities, liver surgery has become the standard of care for hepatocellular carcinoma and …

Background We performed a meta-analysis to assess the benefit of bridging locoregional
treatment (LRT) before liver transplantation for cirrhotic patients with hepatocellular …

Purpose Hepatocellular carcinoma (HCC) is the second leading cause of cancer deaths and
the 7th most common cancer. It has two characteristic features: being advanced stage at …

Simple Summary Hepatocellular carcinoma (HCC) is the fifth most common cancer in men
worldwide and the second leading cause of cancer death. Liver transplantation (LT) is one …

Background: The red blood cell distribution width (RDW) was reported to be related to the
severity of liver diseases, but its clinical significance in patients with hepatocellular …

Die transarterielle Chemoembolisation (TACE) wird bei Patienten mit hepatozellulärem
Karzinom (HCC) als palliative und als neoadjuvante Therapie eingesetzt. Als …